Close Menu

NEW YORK — South Korean diagnostics firm CellSafe said on Wednesday that has signed a distribution agreement with Hong Kong-based Dynasty Castle Investments for CellSafe's LAMPlex RT-qLAMP COVID-19 Detection Assay.

Under the terms of the deal, Dynasty Castle Investments will have the right to sell the test in Portugal and six unspecified African countries in partnership with its local distributors. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.